SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-033114
Filing Date
2020-03-13
Accepted
2020-03-13 16:07:45
Documents
1
Period of Report
2020-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 tm2011481-5_form4.html 4  
1 FORM 4 tm2011481-5_form4.xml 4 3501
  Complete submission text file 0001104659-20-033114.txt   4967
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Issuer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NUVEEN 333 W. WACKER DR. CHICAGO IL 60606
Business Address
Lorenz Kevin (Reporting) CIK: 0001772558 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35366 | Film No.: 20712703